Jump to content

Newfoundland Diagnostics

Add links
From Wikipedia, the free encyclopedia

Newfoundland Diagnostics is a multinational health-testing company headquartered in London, United Kingdom. The company specializes in the development and distribution of diagnostic health tests, both for self-use and professional applications,[1] offering such products available in major retailers for the first time in the United Kingdom.[2]

History

[edit]

Newfoundland Diagnostics was founded in 2020, focusing initially on the distribution of Covid-19 rapid antigen tests. It served as a distributor for Acon Biotech's Flowflex test during the Covid-19 pandemic, becoming a leading player in this field in the United Kingdom,[3] with revenue of over £100m in its first two years of trading.[4]

The company was instrumental in offering diagnostic kits for various medical conditions, such as thyroid function, bowel health, menopause, kidney health, and HIV in a major retailer, notably for the first time in the United Kingdom,[5] and pharmacies across the country.[6][7]

HIV rapid testing

[edit]

In June 2023, Newfoundland Diagnostics entered into an exclusive supply agreement with Atomo Diagnostics (ASX: AT1), for the distribution of rapid self-test HIV kits at retailers in the United Kingdom and Europe.[8][9] This gained notoriety as the world's first commercially available, at-home HIV test, which was sold in major retailers, such as Tesco.[10]

Recent developments

[edit]

In October 2023, the company responded to the anticipated increase in Strep A cases following the 2022–2023 United Kingdom group A streptococcus outbreak by launching Strep A tests in Tesco stores and pharmacies across the United Kingdom.[11] The company aims to provide enough tests to cover 90% of the United Kingdom's at-home testing market.[12][13][14] In May 2024, the company featured within The E2E International 100 track 2024, in association with The Independent. [15]

Market presence and competitive landscape

[edit]

As of 2023, Newfoundland Diagnostics holds one of the largest market shares in the United Kingdom for at-home diagnostic tests.[1] The company's networks extend into public health sectors, pharmaceutical industries, and retail channels across the United Kingdom and Europe. It has also begun to make inroads into the European self-test diagnostic market.[16] In 2024, Newfoundland appointed Hilary Jones (doctor) to an advisory role. [17]

References

[edit]
  1. ^ a b "Service launches to allow quick diagnostic test turnaround". Med-Tech Innovation. 2023-08-16. Retrieved 2023-11-01.
  2. ^ Williams, Holly; Maule, Will (2023-02-27). "Tesco to stock at-home self-diagnosis health tests nationwide". Wales Online. Retrieved 2023-11-01.
  3. ^ "Sigma teams up with Newfoundland Diagnostics". www.pharmacymagazine.co.uk. Retrieved 2023-11-01.
  4. ^ "Companies House Financial Accounts".
  5. ^ "Tesco launches at home tests to shoppers across the UK in first-of-its-kind deal". Lancashire Telegraph. 2023-02-27. Retrieved 2023-11-01.
  6. ^ "At-home health tests launch in Tesco stores nationwide". The Independent. 2023-02-27. Retrieved 2023-11-01.
  7. ^ "Sigma teams up with Newfoundland Diagnostics". www.pharmacynetworknews.com. Retrieved 2023-11-01.
  8. ^ "Atomo and Newfoundland sign agreement for HIV testing in Europe". biotechdispatch.com.au. Retrieved 2023-11-01.
  9. ^ Seymour, Julia (2023-02-28). "Atomo Diagnostics (ASX:AT1) secures $900k order for HIV self-tests". The Market Herald. Retrieved 2023-11-01.
  10. ^ "Tesco launches at home tests to shoppers across the UK in first-of-its-kind deal". The Argus. 2023-02-27. Retrieved 2023-11-01.
  11. ^ "Strep A tests launching in Tesco and pharmacies to help combat winter shortages". www.expressandstar.com. 2023-10-30. Retrieved 2023-11-01.
  12. ^ Williams, Holly (2023-10-30). "Strep A tests launching in Tesco and pharmacies to help combat winter shortages". Evening Standard. Retrieved 2023-11-01.
  13. ^ A. O. L. Staff (2023-10-30). "Strep A tests launching in Tesco and pharmacies to help combat winter shortages". www.aol.co.uk. Retrieved 2023-11-01.
  14. ^ "First at-home HIV tests launched in Tesco as sufferers say stigma continues". The Independent. 2023-11-30. Retrieved 2023-11-30.
  15. ^ "The E2E International 100 track 2024". Independent.co.uk. 29 May 2024.
  16. ^ MarketScreener (2023-02-27). "Atomo Diagnostics Limited Announces Significant Purchase Order for HIV Self-Tests for Europe -February 27, 2023 at 04:58 pm EST | MarketScreener". www.marketscreener.com. Retrieved 2023-11-01.
  17. ^ "NEWFOUNDLAND DIAGNOSTICS APPOINTS DR HILARY JONES TO ADVISORY ROLE". PharmiWeb.com. Retrieved 2024-09-04.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Newfoundland_Diagnostics&oldid=1249788182"